Tech, AI, Web3, and science writer. Drummer and (pre-AI) digital art creator. @DailyAIOfficial @Cerebrum_DAO
South East, England
Joined August 2015
- Tweets876
- Following1.3K
- Followers1K
- Likes1.6K
Sam Jeans retweeted
MAJOR ANNOUNCEMENT ‼️
Cerebrum DAO has partnered with Waves – a browser-based brain health platform grounded in world-class neuroscience.
At the center is Celeste, an AI coach built on SMART (Strategic Memory Advanced Reasoning Tactics), a cognitive neuroscience methodology developed at the UT Dallas Center for BrainHealth:
→ 25+ years of peer-reviewed RCT evidence
→ Validated in 3,966 adults over 3 years
→ Published in Scientific Reports (Nature Portfolio), May 2026
It's time to changeyourwaves.com
Sam Jeans retweeted
Percepta is our flagship product at the Cognition store, but we're working on some new, exciting additions very soon.
Try Percepta for the first time and get 15% off with code CLAW15.
cognition.cerebrumdao.com/pr…
Sam Jeans retweeted
Less than 24 hours to go, join us tomorrow May 13 at 17:00 CEST for our Science Updates AMA.
Register on Luma: luma.com/0lsesq34
We're hosting a live science AMA on Wednesday, May 13 at 17:00 CEST.
Hear updates on our four active IPT projects – @Neuron_Percepta, @FissionBioDeSci, @Transfidelity_ , and @NEURONGale – and ask our science team anything about the research we're funding.
RSVP on Luma: luma.com/0lsesq34
Sam Jeans retweeted
The NEURON-Percepta project tokenized a patent-protected, globally successful supplement, funded a community-led clinical trial, and is now executing on that trial.
If that isn't a true success story of what DeSci can do, we don't know what it is.
Sam Jeans retweeted
A few minutes. Three cognitive domains.
Most people have never had a baseline for their brain.
Cortex gives you one – a Brain Health Score you can track as you make changes to your life.
Let's make brain health actionable!
#BrainHealthUtilityPhase
cortex.cerebrumdao.com
Sam Jeans retweeted
Four brain health IPT projects.
All funded by the community. All targeting different mechanisms behind neurodegeneration.
Here's where each one stands today. ⬇️
Sam Jeans retweeted
We are live on our Q1 2026 Townhall - a lot of updates, outlook, and more. Join us now! Feel free to share your questions as well and we will answer them all.
Sam Jeans retweeted
Thank you for attending our Q1 2026 Townhall.
You can watch the recording if you missed it. Here is what we announced:
💊 Congition is live! Brain Health Supplements.
📱 Cortex App is live! Brain Health Index with NEURON Rewards.
Visit: cerebrumdao.com/
Sam Jeans retweeted
We're getting ready for the next Townhall.
Cortex. Cognition. CerebrAI. IPTs. Exciting results in the pipeline. There's a lot to unpack.
Join us by RSVP'ing below. 👇
luma.com/wr0xdcjs
Sam Jeans retweeted
Cognition is live! 🚀
We have been building this for some time – a dedicated platform for brain health products selected by the Cerebrum DAO community.
Percepta is there, as many of you expected. But we also have a few additions we think you will like.
cognition.cerebrumdao.com/
Sam Jeans retweeted
We are very excited to say Phase 0 of our Cortex app is imminent! ⚡
Current sign-ups will be sent instructions in the next few days.
You can join the 1,000+ who have already signed up for early access here: cerebrumdao.com/cortex-app
Stay tuned for more release information.
Sam Jeans retweeted
We got to a place with heart health where you can measure it, understand risk, and intervene.
That took decades of research and commitment. Brain health is more complex. We're still early. But we will get there.
That's what we're here for. The next frontier in human health.
Sam Jeans retweeted
Cortex is coming.
Your brain changes every day, but most people have no way to track it. Let's change that.
Sam Jeans retweeted
Current anti-inflammatory drugs suppress the immune system.
That's a problem when you're treating diseases that take years to progress – you can't keep someone immunosuppressed indefinitely.
Our compounds can work differently by blocking the link between chronic inflammation and mitochondrial dysfunction.
Currently investigating 15 new drug candidates as we head towards new milestones this year.
Sam Jeans retweeted
The @Neuron_Percepta trial is fully decentralized.
How it works:
→ Participants recruited remotely, products shipped directly to them
→ Wearable sensors track sleep, HRV, and activity continuously
→ At-home blood collection for P-tau 217 biomarker tracking
→ Cognitive assessments administered through dedicated trial software
The result is a depth of data that conventional trial structures simply can't match, paired with the ability to reach participants wherever they are.
View the project and track the results @molecule_DeSci: discovery.molecule.xyz/labs/…
💯
When we tokenized Percepta as $CLAW, supporters were funding a clinical trial for a brain health supplement that had been in development for decades and was backed by numerous patents.
That trial now has IRB approval. It's double-blind, placebo-controlled, tracking robust biomarkers.
This is DeSci at its best – getting science done that wouldn't happen at all otherwise. The potential for powerful patient outcomes doesn't live on a chart.
Sam Jeans retweeted
‼️The Cognition Store launches imminently.
Brain health science backed by community capital, validated through research, available to all.
Sam Jeans retweeted
Inside our @Neuron_Percepta trial.
We're tracking p-Tau 217 through at-home blood collection, running neurocognitive assessments, and integrating wearable monitoring for sleep, HRV, and activity.
All within a 6-month, double-blind, decentralized, randomized placebo-controlled design with IRB approval secured
Sam Jeans retweeted
We set out to find compounds that improve protein printing accuracy. We found something we didn't expect.
Our initial two compounds don't act directly on the translation machinery.
They improve protein fidelity through an indirect pathway, meaning there are new interactions we haven't fully mapped that control how accurately your cells build proteins. This enriches the potential of the Transfidelity project.
